Arteriovenous fistulas represent 68.2% of fistula types sales and transcatheter embolization accounts for 56.3% within the treatment type segment in 2026. The arteriovenous fistula treatment market was valued at USD 868.8 million in 2025, is projected to reach USD 1.63 billion by 2036 and is forecast to post a 5.9% CAGR between 2026 and 2036.